TREATMENT OF AIDS VACUOLAR MYELOPATHY

艾滋病空泡性脊髓病的治疗

• 批准号: 6276365
• 负责人: Alessandro DiRocco
• 金额: $ 6.67万
• 依托单位: MOUNT SINAI SCHOOL OF MEDICINE OF CUNY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6276365
• 关键词: AIDS; AIDS /HIV neuropathy; AIDS therapy; clinical research; drug screening /evaluation; human subject; human therapy evaluation; methionine

This is a Phase III, randomized, double-blind, placebo-controlled, trial of the safety, tolerability and efficacy of methionine for the treatment of AIDS associated vacuolar myelopathy. The study will assess the efficacy of methionine in improving the clinical manifestations of AIDS myelopathy including lower extremity weakness, spasticity, clinical disability and urinary function.

这是III期，随机，双盲，安慰剂对照，试验 蛋氨酸对治疗的安全性，耐受性和功效 与液泡相关的艾滋病。 该研究将评估 蛋氨酸在改善艾滋病的临床表现方面的功效 脊髓病，包括下肢弱点，痉挛，临床 残疾和尿功能。